位置:首页 > 蛋白库 > PTTG2_HUMAN
PTTG2_HUMAN
ID   PTTG2_HUMAN             Reviewed;         202 AA.
AC   Q9NZH5; O95355; Q6NTC9; Q9UNJ6;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 2.
DT   03-AUG-2022, entry version 128.
DE   RecName: Full=Securin-2;
DE   AltName: Full=Pituitary tumor-transforming gene 2 protein;
GN   Name=PTTG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), TISSUE SPECIFICITY, AND
RP   VARIANT PRO-44.
RX   PubMed=10084610; DOI=10.1210/jcem.84.3.5658;
RA   Prezant T.R., Kadioglu P., Melmed S.;
RT   "An intronless homolog of human proto-oncogene hPTTG is expressed in
RT   pituitary tumors: evidence for hPTTG family.";
RL   J. Clin. Endocrinol. Metab. 84:1149-1152(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT PRO-44.
RX   PubMed=10806349; DOI=10.1016/s0378-1119(00)00096-2;
RA   Chen L., Puri R., Lefkowitz E.J., Kakar S.S.;
RT   "Identification of the human pituitary tumor transforming gene (hPTTG)
RT   family: molecular structure, expression, and chromosomal localization.";
RL   Gene 248:41-50(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT PRO-44.
RC   TISSUE=Pituitary adenoma;
RA   Mu Y.;
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q9NZH5-2; O95994: AGR2; NbExp=3; IntAct=EBI-17630019, EBI-712648;
CC       Q9NZH5-2; P67870: CSNK2B; NbExp=3; IntAct=EBI-17630019, EBI-348169;
CC       Q9NZH5-2; A0A0C4DGQ7: EML2; NbExp=3; IntAct=EBI-17630019, EBI-12112376;
CC       Q9NZH5-2; P86480: PRR20D; NbExp=3; IntAct=EBI-17630019, EBI-12754095;
CC       Q9NZH5-2; Q9P2K3-2: RCOR3; NbExp=3; IntAct=EBI-17630019, EBI-1504830;
CC       Q9NZH5-2; Q0D2K3: RIPPLY1; NbExp=3; IntAct=EBI-17630019, EBI-10226430;
CC       Q9NZH5-2; P51687: SUOX; NbExp=3; IntAct=EBI-17630019, EBI-3921347;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NZH5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZH5-2; Sequence=VSP_031444;
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in the pituitary, liver,
CC       spleen, prostate, testis, ovary, small intestine and colon. Also
CC       expressed in various pituitary, testicular, liver and ovarian tumors.
CC       {ECO:0000269|PubMed:10084610, ECO:0000269|PubMed:10806349}.
CC   -!- DOMAIN: The N-terminal destruction box (D-box) acts as a recognition
CC       signal for degradation via the ubiquitin-proteasome pathway.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the securin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF116538; AAD41262.2; -; Genomic_DNA.
DR   EMBL; AF200719; AAF72579.1; -; Genomic_DNA.
DR   EMBL; AF095288; AAC64410.1; -; mRNA.
DR   EMBL; AC021106; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069114; AAH69114.1; -; mRNA.
DR   EMBL; BC069400; AAH69400.1; -; mRNA.
DR   CCDS; CCDS54755.1; -. [Q9NZH5-2]
DR   RefSeq; NP_006598.2; NM_006607.2. [Q9NZH5-2]
DR   AlphaFoldDB; Q9NZH5; -.
DR   BioGRID; 115967; 14.
DR   IntAct; Q9NZH5; 7.
DR   STRING; 9606.ENSP00000424261; -.
DR   iPTMnet; Q9NZH5; -.
DR   PhosphoSitePlus; Q9NZH5; -.
DR   BioMuta; PTTG2; -.
DR   DMDM; 357529040; -.
DR   EPD; Q9NZH5; -.
DR   jPOST; Q9NZH5; -.
DR   MassIVE; Q9NZH5; -.
DR   MaxQB; Q9NZH5; -.
DR   PaxDb; Q9NZH5; -.
DR   PeptideAtlas; Q9NZH5; -.
DR   PRIDE; Q9NZH5; -.
DR   Antibodypedia; 43813; 131 antibodies from 18 providers.
DR   DNASU; 10744; -.
DR   Ensembl; ENST00000504686.2; ENSP00000424261.1; ENSG00000250254.2. [Q9NZH5-2]
DR   GeneID; 10744; -.
DR   KEGG; hsa:10744; -.
DR   MANE-Select; ENST00000504686.2; ENSP00000424261.1; NM_006607.3; NP_006598.2. [Q9NZH5-2]
DR   UCSC; uc011bye.3; human. [Q9NZH5-1]
DR   CTD; 10744; -.
DR   DisGeNET; 10744; -.
DR   GeneCards; PTTG2; -.
DR   HGNC; HGNC:9691; PTTG2.
DR   HPA; ENSG00000250254; Low tissue specificity.
DR   MIM; 604231; gene.
DR   neXtProt; NX_Q9NZH5; -.
DR   OpenTargets; ENSG00000250254; -.
DR   PharmGKB; PA34035; -.
DR   VEuPathDB; HostDB:ENSG00000250254; -.
DR   eggNOG; ENOG502S2GG; Eukaryota.
DR   GeneTree; ENSGT00390000009693; -.
DR   HOGENOM; CLU_1363209_0_0_1; -.
DR   InParanoid; Q9NZH5; -.
DR   OMA; PWECNLL; -.
DR   OrthoDB; 323342at2759; -.
DR   TreeFam; TF330797; -.
DR   PathwayCommons; Q9NZH5; -.
DR   SignaLink; Q9NZH5; -.
DR   SIGNOR; Q9NZH5; -.
DR   BioGRID-ORCS; 10744; 36 hits in 1003 CRISPR screens.
DR   GenomeRNAi; 10744; -.
DR   Pharos; Q9NZH5; Tdark.
DR   PRO; PR:Q9NZH5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9NZH5; protein.
DR   Bgee; ENSG00000250254; Expressed in oocyte and 99 other tissues.
DR   Genevisible; Q9NZH5; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0051276; P:chromosome organization; IEA:InterPro.
DR   GO; GO:0045143; P:homologous chromosome segregation; IBA:GO_Central.
DR   GO; GO:2000816; P:negative regulation of mitotic sister chromatid separation; IBA:GO_Central.
DR   InterPro; IPR006940; Securin_separation_inhibitor.
DR   PANTHER; PTHR10418; PTHR10418; 1.
DR   Pfam; PF04856; Securin; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Nucleus; Proto-oncogene;
KW   Reference proteome; SH3-binding.
FT   CHAIN           1..202
FT                   /note="Securin-2"
FT                   /id="PRO_0000319106"
FT   REGION          60..105
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           61..64
FT                   /note="D-box"
FT                   /evidence="ECO:0000250"
FT   MOTIF           163..173
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        70..104
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         179..202
FT                   /note="LQSPSSILSTLDVELPAVCYDIDI -> FAVSFKHSVDPGC (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_031444"
FT   VARIANT         44
FT                   /note="R -> P (in dbSNP:rs6811863)"
FT                   /evidence="ECO:0000269|PubMed:10084610,
FT                   ECO:0000269|PubMed:10806349, ECO:0000269|Ref.3"
FT                   /id="VAR_038956"
SQ   SEQUENCE   202 AA;  22302 MW;  3CBE738EC7817263 CRC64;
     MATLIYVDKE IGEPGTRVAA KDVLKLESRP SIKALDGISQ VLTRRFGKTY DAPSALPKAT
     RKALGTVNRA TEKSVKTNGP RKQKQPSFSA KKMTEKTVKT KSSVPASDDA YPEIEKFFPF
     NLLDFESFDL PEERQIAHLP LSGVPLMILD EEGELEKLFQ LGPPSPVKMP SPPWECNLLQ
     SPSSILSTLD VELPAVCYDI DI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024